The Case for Public Funding and Public Oversight of Clinical Trials

Tracy R. Lewis; Jerome H. Reichman; Anthony D. So

doi:10.2202/1553-3832.1123

Article

The Case for Public Funding and Public Oversight of Clinical Trials

Tracy R. Lewis , Jerome H. Reichman and Anthony D. So

Published/Copyright: January 19, 2007

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

From the journal The Economists' Voice Volume 4 Issue 1

Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.

Published Online: 2007-1-19

You are currently not able to access this content.

Articles in the same Issue

Column
Is a Recession Ahead? The Models Say Yes, but the Mind Says No
Housing Collapse? Bring It On!
The Case for Public Funding and Public Oversight of Clinical Trials
Dirty Money: What the Underworld Understands that Economists Do Not
Deconstructing the China Price

https://doi.org/10.2202/1553-3832.1123

Articles in the same Issue

Column
Is a Recession Ahead? The Models Say Yes, but the Mind Says No
Housing Collapse? Bring It On!
The Case for Public Funding and Public Oversight of Clinical Trials
Dirty Money: What the Underworld Understands that Economists Do Not
Deconstructing the China Price